4'-(4-methylpiperazinomethyl)-2-trifluoromethylbenzophenone, 97.0%, 1g

3-Bromo-2,4-dimethoxypyridine, 97%, 250mg

4-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)benzoic acid, 95.0%, 250mg

(S)-2,4-Diamino-4-oxobutanoic acid hydrate, 95.0%, 10g

anti-GAPDH mouse monoclonal, clone 6C5, 1 ml

methyl 2-(2-acetamido-4-bromophenyl)acetate, 95.0%, 500mg

2-Chloro-4-[(piperidine-1-carbonyl)-amino]-benzenesulfonyl chloride, 98%, 1g

Methyl-(tetrahydrofuran-3-yl)amine hydrochloride, 95.0%, 250mg

5-(Trifluoromethyl)pyridine-2,3-diamine, 95.0%, 5g

(R)-1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 1g

3-Bromo-4-ethylpyridine, 95.0%, 1g

5- tert -Butyl-4,5,6,7-tetrahydro-benzo[ d ]isoxazole-3-carboxylic acid, 95.0%, 250mg

2,2':5',2''-Terthiophene-5-carboxaldehyde>98.0%(HPLC)1g